Clinical Trial Update: Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and Irritability [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of brexpiprazole for adults with major depressive disorder and irritability has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritability
• Major Depressive Disorder

Drugs mentioned

• brexpiprazole (brexpiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Major Depressive Disorder and Irritability | Phase 3 | Status: WITHDRAWN